Suppr超能文献

神经系统中的干细胞。

Stem cells in the nervous system.

作者信息

Maldonado-Soto Angel R, Oakley Derek H, Wichterle Hynek, Stein Joel, Doetsch Fiona K, Henderson Christopher E

机构信息

From the Columbia Stem Cell Initiative (ARM-S, DHO, HW, JS, FKD, CEH); Departments of Pathology and Cell Biology, Neurology and Neuroscience, Center for Motor Neuron Biology and Disease (ARM-S, DHO, HW, FKD, CEH); Project A.L.S./Jenifer Estess Laboratory for Stem Cell Research (DHO, HW, CEH); and Department of Rehabilitation and Regenerative Medicine (ARM-S, JS, FKD, CEH), Columbia University Medical Center, New York, New York.

出版信息

Am J Phys Med Rehabil. 2014 Nov;93(11 Suppl 3):S132-44. doi: 10.1097/PHM.0000000000000111.

Abstract

Given their capacity to regenerate cells lost through injury or disease, stem cells offer new vistas into possible treatments for degenerative diseases and their underlying causes. As such, stem cell biology is emerging as a driving force behind many studies in regenerative medicine. This review focuses on the current understanding of the applications of stem cells in treating ailments of the human brain, with an emphasis on neurodegenerative diseases. Two types of neural stem cells are discussed: endogenous neural stem cells residing within the adult brain and pluripotent stem cells capable of forming neural cells in culture. Endogenous neural stem cells give rise to neurons throughout life, but they are restricted to specialized regions in the brain. Elucidating the molecular mechanisms regulating these cells is key in determining their therapeutic potential as well as finding mechanisms to activate dormant stem cells outside these specialized microdomains. In parallel, patient-derived stem cells can be used to generate neural cells in culture, providing new tools for disease modeling, drug testing, and cell-based therapies. Turning these technologies into viable treatments will require the integration of basic science with clinical skills in rehabilitation.

摘要

鉴于干细胞具有再生因损伤或疾病而丢失的细胞的能力,它们为退行性疾病及其潜在病因的可能治疗方法提供了新的前景。因此,干细胞生物学正在成为再生医学许多研究背后的驱动力。本综述重点关注目前对干细胞在治疗人类脑部疾病中的应用的理解,尤其侧重于神经退行性疾病。文中讨论了两种类型的神经干细胞:存在于成体大脑中的内源性神经干细胞以及能够在培养中形成神经细胞的多能干细胞。内源性神经干细胞在整个生命过程中都能产生神经元,但它们局限于大脑中的特定区域。阐明调节这些细胞的分子机制是确定它们的治疗潜力以及找到激活这些特殊微环境之外休眠干细胞的机制的关键。与此同时,患者来源的干细胞可用于在培养中生成神经细胞,为疾病建模、药物测试和基于细胞的治疗提供新工具。将这些技术转化为可行的治疗方法需要基础科学与康复临床技能的整合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0727/4197112/268ea13ea029/nihms-574690-f0001.jpg

相似文献

1
Stem cells in the nervous system.神经系统中的干细胞。
Am J Phys Med Rehabil. 2014 Nov;93(11 Suppl 3):S132-44. doi: 10.1097/PHM.0000000000000111.
9
Stem cells and neurodegenerative diseases.干细胞与神经退行性疾病。
Sci China C Life Sci. 2008 Apr;51(4):287-94. doi: 10.1007/s11427-008-0049-1. Epub 2008 Mar 27.

引用本文的文献

5
Lactobacillus for ribosome peptide editing cancer.乳杆菌用于核糖体肽编辑癌症。
Clin Transl Oncol. 2023 Jun;25(6):1522-1544. doi: 10.1007/s12094-022-03066-5. Epub 2023 Jan 24.
6
Regenerative Medicine Therapy in Malaysia: An Update.马来西亚的再生医学疗法:最新进展
Front Bioeng Biotechnol. 2022 Apr 26;10:789644. doi: 10.3389/fbioe.2022.789644. eCollection 2022.
7
A Stem Cell Surge During Thyroid Regeneration.甲状腺再生过程中的干细胞激增。
Front Endocrinol (Lausanne). 2021 Jan 21;11:606269. doi: 10.3389/fendo.2020.606269. eCollection 2020.

本文引用的文献

5
Stem cell therapy in amyotrophic lateral sclerosis.肌萎缩侧索硬化症的干细胞治疗。
J Clin Neurosci. 2013 Dec;20(12):1659-63. doi: 10.1016/j.jocn.2013.04.024. Epub 2013 Oct 19.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验